Bill > HB1087

This bill aims to support schools in obtaining and maintaining opioid overdose reversal medication, such as nasal spray versions like Narcan, to help prevent fatal overdoses. The legislation allows the state's division of mental health and addiction to develop funding applications for schools to acquire FDA-approved overdose reversal medications, subject to available funding. The bill requires the state health commissioner to issue a statewide standing order providing at least two individual doses of an FDA-approved opioid overdose reversal medication for each school or school corporation. Schools will be permitted to store these emergency medications in a safe location accessible only to school employees and can work with opioid overdose prevention organizations. The bill also allows healthcare providers and pharmacists to write, transmit, and dispense prescriptions for these emergency medications specifically for schools. The provisions are set to take effect on July 1, 2026, giving schools and health authorities time to prepare for implementation. By providing schools with readily available overdose reversal medication, the bill seeks to potentially save lives in the event of an opioid overdose on school premises.

Health and Social Services

https://iga.in.gov/legislative/2026/bills/house/1087/details